[Chemical neurolysis using alcohol (alcoholization) in the treatment of spasticity in the hemiplegic].

Cah Anesthesiol

Service de rééducation fonctionnelle et de réadaptation, Hôpital Carémeau, Nîmes.

Published: July 1993

Spasticity is a source of disability for the hemiplegic patient. It leads to various disorders influencing the quality of gait: at the lower limb varus equinus foot deformity, toe-claw and/or hip adduction with adductors spasticity. At the upper limb, flexion deformity of the wrist and the hand makes grasp and grip ineffective and spasticity of the Pectoralis Major muscle is considered as a main cause of sympathetic dystrophy. Neurolysis with alcohol injection in the nerve trunk or at the motor point destroys the gamma fibers and reduces spasticity, without impairing motor command. The effects on spasticity, motricity, and deformity of 33 chemical neurolysis with alcohol are analysed with a six months follow-up (27 hemiplegic patients, 28 to 62 years old, mean = 54.5). The authors have used 60% alcohol concentration. Sciatic nerve injection significantly reduces triceps spasticity (7/11), improves the range motion of the ankle, and allows the patient to take off the ankle device. Those fair results are still present at the fourth month after injection. Similar results are reported after injection of the obturator nerve for hip adduction deformity (2/3), median nerve injection for wrist and hand deformity (6/6). Pectoralis Major injection in the motor point is effective for 10 of the 13 cases, preventing sympathetic reflex dystrophy or contributing to its dramatic improvement.

Download full-text PDF

Source

Publication Analysis

Top Keywords

neurolysis alcohol
12
hip adduction
8
wrist hand
8
pectoralis major
8
motor point
8
nerve injection
8
spasticity
7
injection
6
deformity
5
[chemical neurolysis
4

Similar Publications

MRI-guided neurolysis for the treatment of chronic refractory knee pain: a case report.

Skeletal Radiol

November 2024

Department of Diagnostic and Interventional Radiology, School of Medicine & Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.

Article Synopsis
  • - The case report discusses a new treatment for chronic knee pain, particularly when other therapies have failed, highlighting a patient who underwent MRI-assisted chemical neurolysis targeting the genicular nerve.
  • - A 62-year-old man experienced significant pain relief for four months after the procedure, suggesting that this method could be an effective option for those with persistent knee pain.
  • - Despite promising results, further research, including controlled trials, is needed to fully assess the safety and effectiveness of this treatment before it can be commonly used in clinical practice.
View Article and Find Full Text PDF
Article Synopsis
  • Chemical neurolysis of the genicular nerves offers a potential treatment for chronic, non-cancer knee pain, as reviewed in a study analyzing various research findings.
  • The scoping review included 8 studies (192 patients) examining the effects of chemical neurolysis using either phenol or alcohol, with positive outcomes for pain relief and functionality reported across the board.
  • However, due to variability in study designs and small sample sizes, more high-quality randomized controlled trials are necessary to enhance the understanding of this treatment approach and to compare it with other pain management strategies.
View Article and Find Full Text PDF

: Despite the availability of treatments such as surgery and hormonal therapy, women with endometriosis often endure chronic problems. This review aims to evaluate the effectiveness and safety of neuropelveology. : In a systematic review with a meta-analysis, we searched three electronic databases: MEDLINE (PubMed), Scopus, Embase, and Web of Science (WOS).

View Article and Find Full Text PDF

Background And Objective: To compare the efficacy of EUS-guided celiac plexus neurolysis (CPN) and celiac plexus irradiation with iodine-125 (I) seeds with absolute ethanol for relieving pain in patients with advanced pancreatic cancer.

Methods: We retrospectively analyzed data of 81 patients with advanced pancreatic cancer who underwent EUS-CPN or EUS-I implantation between January 2017 and December 2020. Postoperative pain was assessed using visual analog scale (VAS) scores; self-assessments of quality of life and the median survival time were compared between the 2 groups.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!